Elsevier

World Neurosurgery

Volume 83, Issue 6, June 2015, Pages 1180.e13-1180.e17
World Neurosurgery

Case Report
Spontaneous Hemorrhage from Central Nervous System Hemangioblastomas

https://doi.org/10.1016/j.wneu.2015.02.009Get rights and content

Objective

Hemagioblastomas are highly vascular tumors that rarely present with hemorrhage. To date, the only factor reported to possibly influence the propensity of a tumor to bleed has been its size (>1.5 cm). Here, we present our series of hemorrhagic hemangioblastomas, which includes 2 very small tumors (<1.5 cm). We propose that other factors apart from size may predispose tumors to hemorrhage.

Methods

We conducted a retrospective analysis of 55 cases of central nervous system hemangioblastomas operated on at Harborview Medical Hospital and the University of Washington between 2004 and 2014. Demographical and clinical data were collected and analyzed to determine factors that may predispose these tumors to hemorrhage.

Results

Of 55 cases, only 3 patients presented with hemorrhage (5.5%). None of the patients were von Hippel-Lindau positive. Two of the hemorrhagic tumors were less than 1.5 cm, countering previous studies in which authors proposed that hemangioblastomas that are less than 1.5 cm have essentially no risk of hemorrhage. One tumor also rebled after preoperative embolization.

Conclusions

Our series suggests that small hemangioblastomas may represent a hemorrhagic risk. We speculate that other factors, such as genetic predisposition caused by single-nucleotide polymorphisms, may play a role in hemangiobalstomas that present with rupture.

Introduction

Central nervous system (CNS) hemangioblastomas are highly vascular tumors typically found in the posterior fossa or medullary substance of the spinal cord and represent approximately 2%–3% of all CNS tumors (13). Hemangioblastomas may be associated with von Hippel-Lindau (VHL) syndrome, where they occur with a prevalence of 20%–30% (21). Presenting symptoms of cerebellar hemangioblastomas typically relate to hydrocephalus (headache, nausea, vomiting, diplopia, etc) whereas spinal hemangioblastomas typically present with focal neurologic deficit related to mass effect. On very rare occasions, hemangioblastomas of the brain or spine may present with spontaneous subarachnoid, intra-ventricular, or intra-parenchymal hemorrhage. Fifty-three such cases reports exist in the literature 2, 3, 4, 5, 6, 7, 8, 9, 11, 12, 13, 14, 15, 16, 17, 19, 20, 22, 24, 25, 26, 28, 29, with only one of these studies attempting to systematically evaluate risk factors that may predispose certain hemangioblastomas to spontaneous hemorrhage (13). Glasker et al. 12, 13 postulated that size alone was the most important risk factor for spontaneous hemorrhage, concluding that tumors <1.5 cm pose essentially no risk of hemorrhage. Here, we challenge this hypothesis by presenting our series of hemorrhagic hemangioblastomas, 2 of which were smaller than 1.5 cm in maximal diameter. The potential pathophysiology of hemorrhage in these tumors is also discussed.

Section snippets

Methods

This study was approved by the institutional review board. We retrospectively reviewed our clinical database of patients with CNS hemangioblastomas from 2004 to 2014. Clinical features such as tumor size, location, VHL status, radiography features, and clinical symptoms at presentation and follow-up were evaluated and correlated to the risk of spontaneous hemorrhage. Statistical analysis was performed with Student t-test.

Retrospective Analysis

We encountered pathologically confirmed hemangioblastomas in 53 patients over 10 years. Forty-six were intracranial, 6 were cervical, and 3 were thoracic; one patient had an intracranial and 2 cervical lesions resected. Seven (13%) tumors were designated small tumors with <1.5 cm in maximum dimension (3 intracranial, 3 cervical, 1 thoracic). Three (5.5%) tumors presented with hemorrhage with 1 case of intraparenchymal/tumor hemorrhage (case 1) and 2 cases of combined

Discussion

Intracranial hemangioblastomas are the most common primary tumors of the posterior fossa in adults. Although they often are hypervascular, they rarely present with spontaneous hemorrhage. Our rupture rate of 5.5% is slightly greater than that of other series (1%–3%) (13) and our report presents compelling data that factors other than size play a role in sporadic hemangioblastoma hemorrhage. This is noteworthy as the only study to date that has tried to examine the hemorrhagic risk of

References (29)

  • D. Chauvet et al.

    Multiple spinal hemangioblastomas complicated with postoperative remote cerebellar hemorrhage: review of the literature of two rare entities

    World Neurosurg

    (2014)
  • M. Djindjian

    Successful removal of a brainstem hemangioblastoma

    Surg Neurol

    (1986)
  • M. Minami et al.

    Cervical hemangioblastoma with a past history of subarachnoid hemorrhage

    Surg Neurol

    (1998)
  • A.S. Achrol et al.

    UCSF BAVM Study Project: Tumor necrosis factor-alpha-238G>A promoter polymorphism is associated with increased risk of new hemorrhage in the natural course of patients with brain arteriovenous malformations

    Stroke

    (2006)
  • A.B. Adegbite et al.

    Supratentorial capillary hemangioblastoma presenting with fatal spontaneous intracerebral hemorrhage

    Neurosurgery

    (1983)
  • M. Al-Najar et al.

    Sporadic lateral ventricular hemangioblastoma presenting with intraventricular and subarachnoid haemorrhage

    Sultan Qaboos Univ Med J

    (2013)
  • A. Berlis et al.

    Subarachnoid haemorrhage due to cervical spinal cord haemangioblastomas in a patient with von Hippel-Lindau disease

    Acta Neurochir

    (2003)
  • T.R. Browne et al.

    Hemangioblastoma of the spinal cord. Review and report of five cases

    Arch Neurol

    (1976)
  • A. Cerejo et al.

    Spinal cord hemangioblastoma with subarachnoid hemorrhage

    Neurosurgery

    (1990)
  • J.R. de San Pedro et al.

    Massive hemorrhage in hemangioblastomas Literature review

    Neurosurg Rev

    (2010)
  • M. Fontanella et al.

    Brain arteriovenous malformations are associated with interleukin-1 cluster gene polymorphisms

    Neurosurgery

    (2012)
  • M. Gekka et al.

    Hemorrhagic onset of hemangioblastoma located in the dorsal medulla oblongata presenting with tako-tsubo cardiomyopathy and neurogenic pulmonary edema: a case report

    Case Rep Neurol

    (2014)
  • S. Glasker et al.

    The impact of molecular genetic analysis of the VHL gene in patients with haemangioblastomas of the central nervous system

    J Neurol Neurosurg Psychiatry

    (1999)
  • S. Glasker et al.

    Risk of hemorrhage in hemangioblastomas of the central nervous system

    Neurosurgery

    (2005)
  • Cited by (12)

    • Hemangioblastomas of the Posterior Cranial Fossa in Adults: Demographics, Clinical, Morphologic, Pathologic, Surgical Features, and Outcomes. A Systematic Review

      2018, World Neurosurgery
      Citation Excerpt :

      Because there was only a small sample of patients with information about both their VHLD status and postoperative complications, we did not analyze the differences in types of complications between sporadic and VHLD cases. Outcomes were described in 154 articles (74.4%), which accounted for 1106 patients (73.0%).1,2,4,5,8,10,12-16,18,23,24,26,27,29,34,36-38,41,42,44,46,48,49,51,52,54-58,60-63,65,67,69-75,77,78,80,81,83-90,92-97,100-103,105-108,110-115,120,122,123,127,129,131,133,135-162,164-170,172-183,190,191,194-196,198-201,203-209 A favorable outcome was the most common result (73.9%), followed by fair outcome (11.1%), and poor outcome (4.7%).

    • Safety and outcomes of preoperative embolization of intracranial hemangioblastomas: A systematic review

      2016, Clinical Neurology and Neurosurgery
      Citation Excerpt :

      Inherent risks from embolization include medullary and cerebellar infarct, increased ICP from post-embolization edema, and hemorrhage. Our analysis demonstrated an overall complication rate of 11.7% following preoperative embolization [16–22]. The most common complications included hemorrhage in 5 patients and ischemic infarcts in 4 patients.

    • Rare massive hepatic hemangioblastoma: A case report

      2022, World Journal of Gastrointestinal Oncology
    • Spinal cervical extradural hemangioblastoma

      2022, Journal of Craniovertebral Junction and Spine
    View all citing articles on Scopus

    Conflict of interest statement: Dr. Kim is a consultant for Aesculap Inc. and a stock-holder in SpiSurgical. Dr. Sekhar is stock-holder in SpiSurgical, and Viket Medical, Inc.

    View full text